In the past, biological treatability studies were directed toward defi
ning effluent BOD and TSS. Recent regulations now require effluent lim
itations on volatile organic carbon, specific priority pollutants, aqu
atic toxicity and in many cases nitrogen for complex wastewaters. This
, in turn, has changed the focus of biological treatability studies. I
t is assumed that a screening protocol has been employed to define bio
logical treatment as a candidate process [1]. (a) Priority Pollutants-
If on or more priority pollutants are a permit issue, a fed batch reac
tor (FBR) is run using acclimated biosolids to determine the maximum d
egradation rate, q(m), and the half velocity constant, K-s. From these
data, the required SRT to meet effluent limitations can be computed.
(b) Aquatic Toxicity-If the wastewater exhibits aquatic toxicity in ad
dition to priority pollutant requirements, bioassays are run on the bi
ological units. Effluent toxicity and COD are tracked with time. Since
effluent toxicity is frequently associated with soluble microbial pro
ducts (SMP), the SMP is estimated from the effluent COD over time of a
eration. (c) Nitrogen-Many organics including SMP are inhibitory to ni
trification. The nitrification. rate should be determined on the efflu
ents using seeded NH4Cl as a control. From these data, the required SR
T can be computed. This paper reviews the required protocols and prese
nts several case histories from the chemical and pharmaceutical indust
ry.